Literature DB >> 7386217

Calcium antagonistic effects of terodiline in rabbit aorta and human uterus.

J R Ostergaard, K Ostergaard, K E Andersson, L Sommer.   

Abstract

The possible calcium antagonistic action of the anti-anginal drug terodiline was investigated by two experimental techniques. In isolated preparations of rabbit aorta and pregnant human uterus exposed to a calcium-free medium and then depolarized by potassium, terodiline in concentrations of 4.5--36 microM inhibited contractions produced by cumulative addition of calcium to the extracellular medium. This effect of terodiline could be reversed by high concentrations of calcium. Within the same concentration range, terodiline also reduced potassium-induced 45Ca influx in isolated aorta without affecting calcium efflux. It is suggested that terodiline, which structurally has similarities to prenylamine and fendiline, like these drugs can be classified as a calcium antagonist.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7386217     DOI: 10.1111/j.1600-0773.1980.tb03243.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  5 in total

1.  Block and modified gating of cardiac calcium channel currents by terodiline.

Authors:  T Ogura; S Jones; L M Shuba; J R McCullough; T F McDonald
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.

Authors:  H D Langtry; D McTavish
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

3.  Pharmacokinetics of terodiline in human volunteers.

Authors:  B Karlén; K E Andersson; G Ekman; S Strömberg; U Ulmsten
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  In vitro effects of calcium entry blockers, chlorpromazine and fenoterol upon human pregnant myometrium contractility.

Authors:  G Ballejo; J B Calixto; Y S Medeiros
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

Review 5.  Current concepts in the treatment of disorders of micturition.

Authors:  K E Andersson
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.